Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Cash & Current Investments: 2012-2016

Historic Cash & Current Investments for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to $58.3 million.

  • Tvardi Therapeutics' Cash & Current Investments rose 44.19% to $103.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $310.5 million, marking a year-over-year decrease of 13.55%. This contributed to the annual value of $58.3 million for FY2016, which is 45.40% down from last year.
  • Per Tvardi Therapeutics' latest filing, its Cash & Current Investments stood at $58.3 million for FY2016, which was down 45.40% from $106.7 million recorded in FY2015.
  • Tvardi Therapeutics' 5-year Cash & Current Investments high stood at $106.7 million for FY2015, and its period low was $1.1 million during FY2012.
  • In the last 3 years, Tvardi Therapeutics' Cash & Current Investments had a median value of $58.3 million in 2016 and averaged $72.6 million.
  • As far as peak fluctuations go, Tvardi Therapeutics' Cash & Current Investments surged by 1,006.27% in 2013, and later tumbled by 45.40% in 2016.
  • Tvardi Therapeutics' Cash & Current Investments (Yearly) stood at $1.1 million in 2012, then soared by 1,006.27% to $12.4 million in 2013, then spiked by 326.18% to $52.7 million in 2014, then skyrocketed by 102.69% to $106.7 million in 2015, then slumped by 45.40% to $58.3 million in 2016.